Waypoint Capital Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Waypoint Capital Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$16.6M	Sell
2022 Q4	$18.8M	Sell
2022 Q3	$11.4M	Buy
2022 Q2	$4.31M	Sell
2022 Q1	$8.72M	Buy
2021 Q4	$6.04M	Buy